Suppr超能文献

合成小分子作为对抗抗生素耐药性的抗生物膜剂。

Synthetic small molecules as anti-biofilm agents in the struggle against antibiotic resistance.

机构信息

Dipartimento di Scienze e Tecnologie Biologiche, Chimiche e Farmaceutiche, Sezione di Chimica e Tecnologie Farmaceutiche, Università degli Studi di Palermo, Via Archirafi 32, 90123, Palermo, Italy.

Department of Medical Oncology, VU University Medical Center, Cancer Center Amsterdam, De Boelelaan 1117, 1081HV, Amsterdam, the Netherlands; Cancer Pharmacology Lab, AIRC Start-Up Unit, University of Pisa, via Paradisa, 56100, Pisa, Italy.

出版信息

Eur J Med Chem. 2019 Jan 1;161:154-178. doi: 10.1016/j.ejmech.2018.10.036. Epub 2018 Oct 17.

Abstract

Biofilm formation significantly contributes to microbial survival in hostile environments and it is currently considered a key virulence factor for pathogens responsible for serious chronic infections. In the last decade many efforts have been made to identify new agents able to modulate bacterial biofilm life cycle, and many compounds have shown interesting activities in inhibiting biofilm formation or in dispersing pre-formed biofilms. However, only a few of these compounds were tested using in vivo models for their clinical significance. Contrary to conventional antibiotics, most of the anti-biofilm compounds act as anti-virulence agents as they do not affect bacterial growth. In this review we selected the most relevant literature of the last decade, focusing on the development of synthetic small molecules able to prevent bacterial biofilm formation or to eradicate pre-existing biofilms of clinically relevant Gram-positive and Gram-negative pathogens. In addition, we provide a comprehensive list of the possible targets to counteract biofilm formation and development, as well as a detailed discussion the advantages and disadvantages of the different current biofilm-targeting strategies.

摘要

生物膜的形成极大地促进了微生物在恶劣环境中的生存,目前被认为是导致严重慢性感染的病原体的关键毒力因子。在过去的十年中,人们做出了许多努力来识别能够调节细菌生物膜生命周期的新试剂,许多化合物在抑制生物膜形成或分散已形成的生物膜方面表现出了有趣的活性。然而,只有少数这些化合物在体内模型中测试了它们的临床意义。与传统抗生素不同,大多数抗生物膜化合物作为抗毒力剂起作用,因为它们不会影响细菌的生长。在这篇综述中,我们选择了过去十年中最相关的文献,重点介绍了能够预防临床相关革兰氏阳性和革兰氏阴性病原体形成细菌生物膜或消除已存在生物膜的合成小分子的开发。此外,我们还提供了一个对抗生物膜形成和发展的潜在靶点的综合清单,并详细讨论了不同当前生物膜靶向策略的优缺点。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验